Certain peripheral and tumor‐infiltrating immune cells, such as NK cells, CD3 + T cells, CD8 + T cells, and Foxp3 + Tregs, that are reportedly correlated with better gastric cancer prognoses, have been recommended for predicting prognosis and assessing therapeutic outcomes at the clinical level.18, 19. Here, CD8A is linked to gastric cancer.